# The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot

> **NCT00605423** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 6 (actual)

## Conditions studied

- Age Related Macular Degeneration

## Interventions

- **DRUG:** Fluocinolone Acetonide/Medidur
- **DRUG:** Fluocinolone Acetonide/Medidur

## Key facts

- **NCT ID:** NCT00605423
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2014-04-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00605423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00605423, "The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00605423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*